Dentavations provided a water carries removal system

Neonatal Rescue provides a ventilator device to help newborn babies breathe

EMR and billing software for PTs and OTs

Products that optimize enteral feeding and prevent aspiration pneumonia

A device for monitoring patients on a respirator and patients fed through tubes has been developed by Israeli spinoff company, ART Medical. It offers products that optimize enteral feeding as well as detect and prevent aspiration pneumonia (lat. Pneumoniae), VAP, and kidney. Tube-related reflux and secretion may cause aspiration pneumonia (AP) and ventilator-associated pneumonia (VAP). Both are dangerous complications unrelated to the original reason for hospitalization in the intensive care unit (ICU). These complications result in prolonged lengths of stay and higher risk of mortality. In order to minimize the risk, gastric reflux and saliva must be identified in real-time and treated immediately. 


CellScope provides smarter family care

CellScope, the San Francisco-based company, is bringing diagnostic imaging to the mobile platform, with optical attachments and clever software. The company has launched CellScope Oto, which turns a smartphone into a digital otoscope with seamless, secure data transmission. Clinicians use their system to share images and video with patients and colleagues, and track changes over time. For home users, their technology will dramatically improve remote telemedicine diagnosis, adding the critical images and video of the condition. CellScope technology enables virtual visits saving time and money, as well as watchful waiting, avoiding the harm of unnecessary antibiotics.


CardioCube voice-based AI system can manage your heart disease

Every patient would love to have his own, personal doctor at home. CardioCube, a Los Angeles-based spinoff, provides a voice-based AI software that is an everyday companion to help manage the chronic heart disease. Every patient would love to have his own, personal doctor at home. Furthermore, with the use of CardioCube, patient' healthcare provider in the hospital or clinic gets the disease insights for better and faster decisions directly. The company was founded by Oskar Kiwic, Przemysław Magaczewski and Tom Jadczyk in 2016. It has already received a total of $300,000 in funding over 2 rounds.

2018.10.30 provides the engine that drives truly personalized health and wellness

Diabetic biomarker test

Novel biomarker test predicts high-grade prostate cancer

Cardiologs - the first ECG solution powered by AI

Ambulatory ECG analysis and reporting is a labor-intensive process, resulting in important costs and delays for arrhythmia detection. By applying the latest research in Artificial intelligence and digital biomarkers, Cardiologs provides a web solution to streamline this process at a large scale, enabling the highest diagnostic yield, for the least physician effort. Currently, FDA cleared and CE marked, Cardiologs can read ECG recordings from any digital device. Take an ECG signal, upload it to the Cardiologs cloud and get to the report in a few clicks.


SkinIO - a full-body imaging mapping system can detect skin cancer

The challenge of skin cancer (lat. Carcinoma) is not that there isn't yet a cure; it is that people aren't detecting skin cancer early enough in too many cases. However, ECD-Network, LLC, which is a Chicago-based spinoff, developed an innovative SkinIO app, which uses digital biomarkers in order to detect skin cancer. The companies mission is to make skin cancer screening and skin health monitoring accessible to everyone, whether at the doctor's office or in the comforts of home. Developers claim that skin checking should be a habit, not an exception. This groundbreaking mobile app scans photos for signs of skin cancer and flags them. ECD-Network, LLC was founded in 2008.


Snap40 provides a remotely manage health

Snap40 provides continuous automated risk analysis so health services can identify people at high risk of deterioration. The Edinburgh-based company developed a device that monitors users via its single medical-grade wearable device, worn on the upper arm. This includes relative changes in systolic blood pressure, respiratory rate, heart rate, mobility, blood oxygen saturation, and temperature, as well as perspiration and movement levels. Automatic notifications of patients at high risk of deterioration, sent via the company’s mobile and web applications, allow healthcare staff to intervene early and prevent further deterioration. This reduces the length of hospital stay, thereby reducing costs, as well as saving lives and improving patient outcomes.


Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.